` Comparison: CSJ vs PFE - Alpha Spread

CSJ
vs
PFE

Over the past 12 months, CSJ has underperformed PFE, delivering a return of -37% compared to the PFE's +23% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CSJ
PFE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CSJ Intrinsic Value
128.27 EUR
Undervaluation 34%
Intrinsic Value
Price €84.35
PFE Intrinsic Value
32.01 USD
Undervaluation 15%
Intrinsic Value
Price $27.11
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
CSL Ltd
SWB:CSJ
84.35 EUR
Pfizer Inc
NYSE:PFE
27.11 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CSJ, PFE

CSJ
PFE
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
CSL Ltd
Revenue
Pfizer Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CSJ, PFE

CSJ
PFE
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
CSL Ltd
SWB:CSJ
Pfizer Inc
NYSE:PFE
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CSJ
51.9%
PFE
75.8%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

Operating Margin

CSJ
26.1%
PFE
31.8%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

Net Margin

CSJ
9.1%
PFE
12.4%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

FCF Margin

CSJ
16.1%
PFE
14.5%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

ROE

CSJ
7.5%
PFE
8.9%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

ROA

CSJ
3.7%
PFE
3.7%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

ROIC

CSJ
10.4%
PFE
10.9%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

ROCE

CSJ
12.2%
PFE
11.6%
LTM 3Y Avg 5Y Avg 10Y Avg
CSL Ltd
Pfizer Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CSJ, PFE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CSJ, PFE

Loading
CSJ
PFE
Difference
www.alphaspread.com

Performance By Year
CSJ, PFE

Loading
CSJ
PFE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CSJ to other stocks
AMGN
Amgen Inc
More expensive
vs CSJ
BMY
Bristol-Myers Squibb Co
More expensive
vs CSJ
BAX
Baxter International Inc
Cheaper
vs CSJ
PNEXF
Pharnext SCA
More expensive
vs CSJ
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett